Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension

Arthritis and Rheumatism

Volumn 65, Issue 9, 2013, Pages 2403-2411

  Codullo, Veronica ^a   Caporali, Roberto ^a   Cuomo, Giovanna ^b   Ghio, Stefano ^a   D'Alto, Michele ^b   Fusetti, Chiara ^a   Borgogno, Elena ^a   Montecucco, Carlomaurizio ^a   Valentini, Gabriele ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COCHIN RISK PREDICTION SCORE; DIAGNOSTIC TEST ACCURACY STUDY; EXERCISE; EXERCISE TEST; FEMALE; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HEART INDEX; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING;

ADULT; AGED; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 84883214149     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38043     Document Type: Article

References (24)

1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al, ESC Committee for Practice Guidelines. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [published erratum appears in Eur Heart J 2011;32:926]. Eur Heart J 2009; 30: 2493-537.
2. Avouac J, Airo P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010; 37: 2290-8.
3. Steen VD, Medsger TA,. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
4. Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al, and the ItinerAIR-Sclerodermie Study Group. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009; 60: 1831-9.
5. Chatterjee S,. Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum 2011; 41: 19-37.
6. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009; 60: 569-77.
7. Galie N, Palazzini M, Manes A,. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 2010; 31: 2080-6.
8. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Little Brown; 1994. p. 253-6.
9. Hachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, et al, on behalf of the French PAH -SSc Network. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology (Oxford) 2010; 49: 940-4.
10. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R,. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008; 134: 146-51.
11. Grunig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T, et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 2009; 119: 1747-57.
12. D'Alto M, Ghio S, D'Andrea A, Pazzano AS, Argiento P, Camporotondo R, et al. Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis. Heart 2011; 97: 112-7.
13. Meune C, Avouac J, Airo P, Beretta L, Dieude P, Wahbi K, et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations [published erratum appears in Arthritis Rheum 2011;63:4030]. Arthritis Rheum 2011; 63: 2790-6.
14. Hachulla E, Clerson P, Humbert M,. Could the Cochin risk prediction score be applied in daily practice to predict pulmonary hypertension in systemic sclerosis? Comment on the article by Meune et al [letter]. Arthritis Rheum 2012; 64: 2051-2.
15. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901-3.
16. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
17. Van Buuren S, Boshuizen HC, Knook DL,. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-94.
18. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
19. Grunig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000; 102: 1145-50.
20. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, et al. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176-81.
21. Pattanaik D, Brown M, Postlethwaite AE,. Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 2011; 4: 105-25.
22. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
23. Kovacs G, Maier R, Aberer E, Brodmann M, Graninger W, Kqiku X, et al. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum 2012; 64: 1257-62.
24. Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011; 63: 3522-30.